Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
7.71
+0.06 (0.78%)
At close: Nov 18, 2025, 4:00 PM EST
7.71
0.00 (0.00%)
After-hours: Nov 18, 2025, 7:00 PM EST
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $2 billion as of November 18, 2025. Its market cap has decreased by -58.55% in one year.
Market Cap
2.00B
Enterprise Value
10.17B
1-Year Change
-58.55%
Ranking
Category
Stock Price
$7.71
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $2.00B, a decrease of -76.18%. That is a compound annual growth rate of -27.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 1.99B | -48.24% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | 8.42B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |